These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21371160)

  • 1. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Rong B; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Cardiovasc Electrophysiol; 2011 Aug; 22(8):858-65. PubMed ID: 21371160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation.
    Dabrowski R; Borowiec A; Janas J; Firek B; Kowalik I; Smolis-Bak E; Luczak D; Sosnowski C; Kazimierska B; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
    Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Yoshida N; Toyama J; Yoshida Y; Tsuboi N; Inden Y; Hirai M; Murohara T
    Europace; 2007 Sep; 9(9):770-4. PubMed ID: 17670784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
    Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
    Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A
    Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide (BNP) in patients undergoing mitral valve surgery.
    Filsoufi F; Rahmanian PB; Salzberg S; von Harbou K; Bodian CA; Adams DH
    J Card Surg; 2008; 23(6):600-5. PubMed ID: 18793229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of pre-procedural plasma brain natriuretic peptide level on atrial fibrillation recurrence post radiofrequency catheter ablation].
    Jin YY; Zhang XY; Zhu XL; Ma CS; Long DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):39-42. PubMed ID: 22490632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.
    Wazni OM; Martin DO; Marrouche NF; Latif AA; Ziada K; Shaaraoui M; Almahameed S; Schweikert RA; Saliba WI; Gillinov AM; Tang WH; Mills RM; Francis GS; Young JB; Natale A
    Circulation; 2004 Jul; 110(2):124-7. PubMed ID: 15210589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation.
    Hussein AA; Saliba WI; Martin DO; Shadman M; Kanj M; Bhargava M; Dresing T; Chung M; Callahan T; Baranowski B; Tchou P; Lindsay BD; Natale A; Wazni OM
    Circulation; 2011 May; 123(19):2077-82. PubMed ID: 21536999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke.
    Shibazaki K; Kimura K; Fujii S; Sakai K; Iguchi Y
    Am J Cardiol; 2012 May; 109(9):1303-7. PubMed ID: 22341921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients.
    Arya A; Hindricks G; Sommer P; Huo Y; Bollmann A; Gaspar T; Bode K; Husser D; Kottkamp H; Piorkowski C
    Europace; 2010 Feb; 12(2):173-80. PubMed ID: 19889688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Asanin M; Stankovic S; Mrdovic I; Matic D; Savic L; Majkic-Singh N; Ostojic M; Vasiljevic Z
    Peptides; 2012 May; 35(1):74-7. PubMed ID: 22421508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation.
    Degener S; Pattberg SV; Feuersenger H; Bansmann PM; Shin DI; Krummenauer F; Horlitz M
    J Interv Card Electrophysiol; 2011 Apr; 30(3):217-25. PubMed ID: 21249437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm.
    Beck-da-Silva L; de Bold A; Fraser M; Williams K; Haddad H
    Can J Cardiol; 2004 Oct; 20(12):1245-8. PubMed ID: 15494777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.